MGTX — MeiraGTx Holdings plc
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1735438 ·
Last close
$8.46
Market Cap
$826.80M
52W High
$15.35
52W Low
$6.62
ADV30
747,908
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 4,814,000 | 1,391,000 | -49,878,000 | -51,212,000 | 411,695,000 | 184,650,000 | 196,474,000 |
| Jun 2026 | 321,434,000 | 314,270,000 | 244,425,000 | 160,720,000 | 396,449,000 | 143,166,000 | 180,668,000 |
| Mar 2026 | 293,000 | 95,000 | -40,817,000 | -46,313,000 | 244,655,000 | 71,541,000 | 302,785,000 |
| Dec 2025 | 75,364,000 | 74,888,000 | 26,472,000 | 15,088,000 | 244,430,000 | 65,931,000 | 250,223,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,419,000
Investing CF
$-28,715,000
Financing CF
$196,883,000
CapEx
$-28,982,000
Dividends Paid
—
Buybacks
$-18,193,000
EPS Diluted TTM
$-0.01
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-753,028,000
Inventory
$0
Receivables
$29,560,000
ST Investments
—
EBIT TTM
$91,340,000
Pretax Income TTM
$81,138,000
Interest Exp TTM
$12,477,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$401,904,992
EBITDA
$191,996,992
Free Cash Flow
$47,396,624
Enterprise Value
$846,507,328
Total Cash
$184,650,000
Total Debt
$133,851,000
Shares Out
97,730,540
Trailing EPS
$0.87
Book Value
$2.29
ROE
89.5%
ROA
37.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 81,391,000 | -105,968,000 | -114,201,000 | 244,430,000 | 250,223,000 | -5,793,000 | -46,359,000 |
| Dec 2024 | 33,279,000 | -164,212,000 | -147,791,000 | 269,751,000 | 201,924,000 | 67,827,000 | -104,495,000 |
| Dec 2023 | 14,017,000 | -137,061,000 | -84,027,000 | 326,744,000 | 188,567,000 | 138,177,000 | -105,365,000 |
| Dec 2022 | 15,920,000 | -116,355,000 | -129,615,000 | 318,237,000 | 200,499,000 | 117,738,000 | -73,098,000 |
TTM Snapshot
Revenues TTM
$398,456,000
NetIncome TTM
$78,982,000
OpCashFlow TTM
—
Assets (Latest)
$396,449,000
Forward EPS
$-1.52
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $8.32 · call volume: 89 · put volume: 15Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BBTX | Bambusa Therapeutics, Inc. | $832.91M | $16.35 | — |
| PRME | Prime Medicine, Inc. | $854.20M | $3.84 | — |
| GLUE | Monte Rosa Therapeutics, Inc. | $775.03M | $9.07 | — |
| AURA | Aura Biosciences, Inc. | $744.13M | $7.15 | — |
| ODTX | Odyssey Therapeutics, Inc. | $931.07M | $19.37 | — |
News headlines (Yahoo Finance, 1h cache)
MeiraGTx Announces Oral Presentation at ObesityWeek 2026
2026-11-16 12:00 · Yahoo
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates
2026-11-12 13:15 · Yahoo
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
2026-11-12 13:00 · Yahoo
MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting
2026-10-27 12:00 · Yahoo
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
2026-09-23 12:00 · Yahoo
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
2026-08-14 23:12 · Yahoo
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says
2026-08-14 16:02 · Yahoo
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
2026-08-13 13:25 · Yahoo
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06 20:30 · Yahoo
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
2026-07-15 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.